<menu id="wymuy"><strong id="wymuy"></strong></menu>
  • <menu id="wymuy"><strong id="wymuy"></strong></menu> <menu id="wymuy"></menu>
  • <menu id="wymuy"></menu>
  • <input id="wymuy"></input>
  • Moderna&rsquo;s COVID-19 Vaccine 94 Percent Effective: Initial Data
    Moderna’s COVID-19 Vaccine 94 Percent Effective: Initial Data
    The results mark the second experimental COVID-19 vaccine to show high efficacy, but the study is not complete and the data have not been peer reviewed.
    Moderna’s COVID-19 Vaccine 94 Percent Effective: Initial Data
    Moderna’s COVID-19 Vaccine 94 Percent Effective: Initial Data

    The results mark the second experimental COVID-19 vaccine to show high efficacy, but the study is not complete and the data have not been peer reviewed.

    The results mark the second experimental COVID-19 vaccine to show high efficacy, but the study is not complete and the data have not been peer reviewed.

    clinical research
    Updated
    Pfizer&rsquo;s COVID-19 Vaccine 90 Percent Effective: Initial Data
    Pfizer’s COVID-19 Vaccine 90 Percent Effective: Initial Data
    Max Kozlov | Nov 9, 2020
    Vaccine experts say the results surpass their expectations, but the study is not complete, and the data have not been peer reviewed.
    Scientists Probe Blockers for the Coronavirus Spike Protein
    Scientists Probe Blockers for the Coronavirus Spike Protein
    Anthony King | Nov 5, 2020
    SARS-CoV-2, the virus that causes COVID-19, taps into human proteases such as furin to enter cells. Temporarily inhibiting those enzymes might stymie infection.
    Trials Unlikely to Show if COVID-19 Vaccine Prevents Severe Cases
    Trials Unlikely to Show if COVID-19 Vaccine Prevents Severe Cases
    Max Kozlov | Oct 30, 2020
    A vaccine expert explains that such answers likely won’t come until a vaccine has already been approved and administered to millions of people.
    New Tracer Gives Clear Picture of Alzheimer&rsquo;s and Other Dementias
    New Tracer Gives Clear Picture of Alzheimer’s and Other Dementias
    Ian Le Guillou | Oct 29, 2020
    An imaging agent reveals aggregated tau protein in the brain during PET scans and could improve the diagnosis of neurodegenerative diseases, particularly tauopathies.
    Eli Lilly Halts Antibody Trial in Hospitalized COVID-19 Patients
    Eli Lilly Halts Antibody Trial in Hospitalized COVID-19 Patients
    Ashley Yeager | Oct 27, 2020
    Recent data show that the drug bamlanivimab, also known as LY-CoV555, does not appear to help those with severe cases of COVID-19, but trials continue for milder cases.
    Mexican Senate Votes to Cut Research Funding, Disaster Relief
    Mexican Senate Votes to Cut Research Funding, Disaster Relief
    Lisa Winter | Oct 22, 2020
    Government leaders claim the reductions are necessary to free up assets to deal with COVID-19 and address corruption in research.
    A Challenge Trial for COVID-19 Would Not Be the First of Its Kind
    A Challenge Trial for COVID-19 Would Not Be the First of Its Kind
    Jef Akst | Oct 8, 2020
    Although scientists debate the ethics of deliberately infecting volunteers with SARS-CoV-2, plenty of consenting participants have been exposed to all sorts of pathogens in prior trials.
    What We Know About Donald Trump&rsquo;s COVID-19 Treatment Plan
    What We Know About Donald Trump’s COVID-19 Treatment Plan
    Lisa Winter | Oct 5, 2020
    The President was hospitalized on Friday evening and has been receiving an aggressive treatment of experimental and standard drugs.
    Timothy Ray Brown, First Person to Be Cured of HIV, Dies
    Timothy Ray Brown, First Person to Be Cured of HIV, Dies
    Kerry Grens | Sep 30, 2020
    The AIDS activist, also known as the Berlin patient, represented optimism that scientists could find a way to beat HIV.
    精选二四六天天好彩j